`
`
`
`
`lucentis PFS
`
`
`NS© IFB Update
`
`
`
`June 16, 2071
`
`
`
`
`
`
`
`
`thy NOVARTIS
`
`
`
`
`
`
`
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`
`
`
`NOVITC(CH)00874056
`
`
`
`Novartis Exhibit 2140.001
`Regeneron v. Novartis, IPR202 1-008 16
`
`Novartis Exhibit 2140.001
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`
`
`| Executive Summary
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`NOVITC(CH)00874056
`
`Novartis Exhibit 2140.002
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`NOVITC(CH)00874056
`
`Novartis Exhibit 2140.003
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`PFS key development milestones
`Each milestone must pass successfully to support blue sky vision submission readiness;
`
`contingency plans will result in delay of overall plan
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`NOVITC(CH)00874056
`
`Novartis Exhibit 2140.004
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Key challenges and progress
`= Requirements
`» Status
`
`«Next steps
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`NOVITC(CH)00874056
`
`Novartis Exhibit 2140.005
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Key risks 1/2
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`NOVITC(CH)00874056
`
`Novartis Exhibit 2140.006
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Key risks 2/2
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`NOVITC(CH)00874056
`
`Novartis Exhibit 2140.007
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`BACKUP
`
`tl, NOVARTIS
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`NOVITC(CH)00874056
`
`Novartis Exhibit 2140.008
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`
`
`| Lucentis PFS - Technical Status Update
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`NOVITC(CH)00874056
`
`Novartis Exhibit 2140.009
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Next activities leading to Registration stability manufacture atl/September
`
`2011) —newstopper activities under planning
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`NOVITC(CH)00874056
`
`Novartis Exhibit 2140.0010
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`2: New Plunger Rod
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`NOVITC(CH)00874056
`
`Novartis Exhibit 2140.0011
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Old vs. New stopper design and related process
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`NOVITC(CH)00874056
`
`Novartis Exhibit 2140.0012
`Regeneron v. Novartis, IPR2021-00816
`
`